section name header
Table 17-4
Increase
Increased central neurotransmitter levels (monoamine oxidase inhibitors, acute
dextroamphetamine
administration, cocaine,
ephedrine
, levodopa)
Hyperthermia
Chronic ethanol abuse
Hypernatremia
Decrease
Increasing age
Metabolic acidosis
Hypoxia (PaO
2
38 mm Hg)
Induced hypotension (MAP <50 mm Hg)
Decreased central neurotransmitter levels (
α
-
methyldopa
, reserpine)
α
2
-Agonists
Hypothermia
Hyponatremia
Lithium
Hypo-osmolality
Pregnancy
Acute ethanol administration
Ketamine
Lidocaine
Opioids
Opioid agonistantagonist analgesics
Barbiturates
Diazepam
Hydroxyzine
Delta-9-Tetrahydrocannabinol
Verapamil
Anemia (<4.3 mL oxygen/dL blood)
MAP = mean arterial pressure.